HAGEMAN, ROBERT JOHAN JOSEPH,KAMPHUIS, PATRICK JOSEPH GERARDUS HENDRIKUS,BROERSEN, LADISLAUS MARIA
申请号：
NZ58226508
公开号：
NZ582265A
申请日:
2008.06.20
申请国别(地区):
NZ
年份:
2012
代理人:
摘要：
A composition that comprises: (a) An omega-3 fatty acid selected from DHA, DPA and EPA； (b) Uridine selected from uridine, deoxyuridine, uridine phosphates, uracil and acylated uridine； (c) A methyl donor； (d) A B vitamin； and (e) Mineral and trace elements. The composition is used for treating or preventing the onset or a neurological disorder in a subject having characteristics of a prodromal neurological patient. The disorder can be dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, Mild Cognitive Impairment, memory and cognition problems.
